June 1, 2007Vascular and Endovascular Surgery
Endovascular Repair of Thoracic Aortic Disease: Early and Midterm Experience
Key result
Endovascular stent graft placement for thoracic aorta disease was associated with an 87% 30-day survival rate and low rates of intermediate-term complications over a median 22-month follow-up.
Why the study?
What are the early and midterm outcomes of endovascular stent graft placement in patients with thoracic aortic pathology?
Population
53 consecutive patients with thoracic aortic pathology, mean age 66 years, 34 male.
Design
Cohort
Follow-up
Median 22 months (1 to 72 months)
Authors
Discussion
Loading...
Member takes
Implication
Supports thoracic endovascular repair feasibility in observational data; leaves open need for RCTs versus open surgery.
Study Design
Type
Observational (n=53)
Multicenter
No
Structured PICO
What are the early and midterm outcomes of endovascular stent graft placement in patients with thoracic aortic pathology?
P
Population
53 consecutive patients (mean age 66 years, 36% female) with thoracic aortic pathology treated with endovascular repair, followed for a median of 22 months.
E
Exposure
Endovascular stent graft placement
O
Outcome
Operative 30-day mortality and intermediate-term outcomes (endoleak, stent migration, aneurysmal expansion, reintervention, survival)hard clinical
Endovascular stent graft placement for thoracic aortic disease is feasible and safe, with low complication rates and good intermediate survival, though emergent cases carry higher early mortality.
Limitations
- Long-term efficacy still needs to be evaluated.
- Long-term efficacy still needs to be evaluated
Cite This Study
Chu et al. (2007) conducted an observational in Thoracic aortic pathology (n=53). Endovascular stent graft placement was evaluated on 30-day survival. Endovascular stent graft placement for thoracic aorta disease was associated with an 87% 30-day survival rate and low rates of intermediate-term complications over a median 22-month follow-up.